gliclazide has been researched along with aliskiren in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, LA; El-Latif, HA; Hassanein, NM; Mahfoz, AM; Shoka, AA | 1 |
| Al-Hindi, Y; Alharbi, B; Alkhudhayri, S; Fairaq, A; Qabbani, J; Sajini, R; Yousef, A | 1 |
2 other study(ies) available for gliclazide and aliskiren
| Article | Year |
|---|---|
Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Topics: Amides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fumarates; Gliclazide; Heart Rate; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin-Secreting Cells; Kidney; Oxidative Stress; Rats, Wistar; Streptozocin; Urological Agents | 2016 |
Investigating the beneficial effect of aliskiren in attenuating neuropathic pain in diabetic Sprague-Dawley rats.
Topics: Amides; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Drug Therapy, Combination; Fumarates; Gliclazide; Male; Neuralgia; Ramipril; Rats, Sprague-Dawley; Streptozocin; Treatment Outcome | 2021 |